Clinical trial
Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III…
NCT00054561 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00054561 |
|---|---|
| Title | Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | Phase III Randomized Study of Adjuvant Biologic Therapy in Patients With Stages III/IV Head and Neck Squamous Cell Carcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Dietary Supplement, Drug, Procedure |
| Interventions | recombinant interferon alfa, vitamin E, isotretinoin, adjuvant therapy |
| Start date | Nov 26, 2003 |
| Primary completion | Dec 1, 2004 |
| Completion | May 1, 2009 |
| First posted | Feb 6, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | Australia, Peru, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: